Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials Other Scholarly Work

Garmendia, Craig A, Gorra, Liliana Nassar, Rodriguez, Ana Lucia et al. (2019). Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials . JAMA INTERNAL MEDICINE, 179(4), 582-584. 10.1001/jamainternmed.2018.7661

Open Access

cited authors

  • Garmendia, Craig A; Gorra, Liliana Nassar; Rodriguez, Ana Lucia; Trepka, Mary Jo; Veledar, Emir; Madhivanan, Purnima

sustainable development goals

authors

publication date

  • April 1, 2019

webpage

published in

keywords

  • General & Internal Medicine
  • Life Sciences & Biomedicine
  • Medicine, General & Internal
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER MEDICAL ASSOC

start page

  • 582

end page

  • 584

volume

  • 179

issue

  • 4